Is Sweet Syndrome hereditary?

Sweet Syndrome, also known as acute febrile neutrophilic dermatosis, is generally not considered a hereditary condition. While the exact etiology remains complex, Sweet Syndrome is typically classified as an inflammatory reaction rather than a genetic disorder passed through families.

Is Sweet Syndrome an inherited genetic condition?

Current medical literature does not classify Sweet Syndrome as a hereditary or genetic disorder. It is not caused by a single gene mutation passed from parents to children, and there is no known Mendelian inheritance pattern (such as autosomal dominant or recessive) associated with the disease. In the 73 members of the DiseaseMaps.org community living with Sweet Syndrome, there is no evidence of familial clustering that would suggest a traditional genetic transmission.

What triggers the development of Sweet Syndrome?

While not hereditary, Sweet Syndrome is often linked to underlying systemic triggers. The condition is categorized into three clinical forms based on potential causes:

• Idiopathic Sweet Syndrome: Spontaneous onset with no identifiable underlying cause.


• Malignancy-associated: Linked to hematologic disorders, most commonly acute myeloid leukemia (seen in approximately 10-20% of cases).


• Drug-induced: Triggered by medications such as granulocyte colony-stimulating factor (G-CSF) or certain antibiotics.

Are genetic tests needed for Sweet Syndrome?

Because Sweet Syndrome is not an inherited genetic disease, there are no specific genetic tests to diagnose it. However, clinical geneticists may be involved if a patient’s Sweet Syndrome is secondary to an underlying malignancy that has a genetic component. In these instances, testing is directed at the primary malignancy rather than the dermatosis itself. De novo mutations are not considered a primary driver of Sweet Syndrome, as it is primarily an immune-mediated inflammatory response.

Should families seek genetic counseling?

Genetic counseling is generally not required for Sweet Syndrome unless it is identified as a secondary manifestation of an underlying genetic cancer syndrome. If you are planning a pregnancy and have concerns about the medications used to manage your Sweet Syndrome, consult with a reproductive specialist or a rheumatologist to discuss the safety of your treatment regimen during gestation.

Next steps

• Consult a rheumatologist or dermatologist to manage active inflammation.


• Work with an oncologist to rule out underlying hematologic conditions.


• Join our community of 73 Sweet Syndrome patients at DiseaseMaps.org to share experiences and coping strategies.


• Maintain a detailed log of medication changes, as drug-induced Sweet Syndrome is a recognized clinical subtype.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - Sweet Syndrome entry.


• Orphanet: Acute febrile neutrophilic dermatosis (Sweet Syndrome).


• PubMed: "Sweet Syndrome: A Comprehensive Review of Etiology and Management."


• American Academy of Dermatology (AAD) - Clinical guidelines on neutrophilic dermatoses.